NUVL - CIK 0001861560
The table below shows Nuvalent, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $83.61M | $83.84M | $80.91M | $74.42M | $60.55M | $49.17M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $35.80M |
| $28.85M |
| $23.66M |
| $20.39M |
| $15.78M |
| $15.98M |
| Operating income | -$119.41M | -$112.70M | -$104.57M | -$94.81M | -$76.33M | -$65.15M |
| Income tax | $168.00K | $132.00K | $145.00K | $157.00K | $40.00K | $170.00K |
| Net income | -$109.28M | -$122.44M | -$99.65M | -$84.58M | -$84.34M | -$57.17M |
| EPS (diluted) | -$1.39 | -$1.70 | -$1.39 | -$1.18 | -$1.28 | -$0.88 |